Latigo Biotherapeutics, Inc. (LTGO)
12.50
-0.51
(-3.92%)
USD |
NASDAQ |
Nov 06, 10:21
Latigo Biotherapeutics Net Income (Quarterly) : -25.80M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.80M |
| March 31, 2026 | -22.96M |
| Date | Value |
|---|---|
| June 30, 2025 | -25.84M |
| March 31, 2025 | -20.95M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Turn Therapeutics, Inc. | -5.850M |
| Journey Medical Corp. | -0.312M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 124.49M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.80M |
| EPS Diluted (Quarterly) | -0.3891 |
| Enterprise Value | 1.127B |
| Earnings Yield | -11.94% |
| Normalized Earnings Yield | -11.86 |